MANY MINDEDMouse spleen grafts show immune restoration potential
Chinese researchers published findings in *Advanced Science* showing neonatal thymus tissue transplanted into BALB/c nude mice formed organized thymic tissue in spleens by week two. These grafts reached about 50% of normal thymus weight and supported better recovery of CD8+ T-cells compared to CD4+ T-cells. Recipients controlled vesicular stomatitis virus infection more effectively than untreated mice and showed improved naive T-cell counts in naturally aged mice (20 months old). The spleen grafts also reduced graft-versus-host disease versus muscle grafts and generated antigen-responsive T-cells after ovalbumin challenge.
This work offers a potential pathway to reverse immune aging in humans, but the study explicitly states human trials are required to achieve that outcome. Current results are confined to mice, with T-cell counts remaining substantially below normal controls in all recipients. The approach’s superiority over muscle grafts—particularly for CD8+ T-cell recovery—suggests a mechanism for enhanced immune resilience in aging populations.
For abundance, this research could eventually help older adults maintain immune function without costly treatments. However, it currently moves no human need toward free availability. The next critical step is confirming whether similar grafts work in humans without triggering severe immune responses or failing to restore full immune capacity.
*Note: The source states human trials are required for immune aging reversal. Results observed in mice only; human applicability unproven.*
Source: Lifespan.io